182 related articles for article (PubMed ID: 21320062)
1. Predicting clearance in humans from in vitro data.
Obach RS
Curr Top Med Chem; 2011; 11(4):334-9. PubMed ID: 21320062
[TBL] [Abstract][Full Text] [Related]
2. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Drug Metabolism Using Liver Microsomes.
Knights KM; Stresser DM; Miners JO; Crespi CL
Curr Protoc Pharmacol; 2016 Sep; 74():7.8.1-7.8.24. PubMed ID: 27636111
[TBL] [Abstract][Full Text] [Related]
4. The prediction of human clearance from hepatic microsomal metabolism data.
Obach RS
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
[TBL] [Abstract][Full Text] [Related]
5. The human drug metabolizing cytochromes P450.
Wrighton SA; VandenBranden M; Ring BJ
J Pharmacokinet Biopharm; 1996 Oct; 24(5):461-73. PubMed ID: 9131485
[TBL] [Abstract][Full Text] [Related]
6. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
[TBL] [Abstract][Full Text] [Related]
7. The role of drug metabolizing enzymes in clearance.
Di L
Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):379-93. PubMed ID: 24392841
[TBL] [Abstract][Full Text] [Related]
8. Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data.
Cubitt HE; Houston JB; Galetin A
Drug Metab Dispos; 2011 May; 39(5):864-73. PubMed ID: 21303923
[TBL] [Abstract][Full Text] [Related]
9. Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.
Iwatsubo T; Hirota N; Ooie T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Sugiyama Y
Pharmacol Ther; 1997; 73(2):147-71. PubMed ID: 9131722
[TBL] [Abstract][Full Text] [Related]
10. Predicting drug pharmacokinetics in humans from in vitro metabolism studies.
McGinnity DF; Riley RJ
Biochem Soc Trans; 2001 May; 29(Pt 2):135-9. PubMed ID: 11356141
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
[TBL] [Abstract][Full Text] [Related]
12. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.
Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143
[TBL] [Abstract][Full Text] [Related]
13. Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance.
Hakooz N; Ito K; Rawden H; Gill H; Lemmers L; Boobis AR; Edwards RJ; Carlile DJ; Lake BG; Houston JB
Pharm Res; 2006 Mar; 23(3):533-9. PubMed ID: 16505976
[TBL] [Abstract][Full Text] [Related]
14. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data.
Li XQ; Björkman A; Andersson TB; Gustafsson LL; Masimirembwa CM
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):429-42. PubMed ID: 12920490
[TBL] [Abstract][Full Text] [Related]
15. Use of intrinsic clearance for prediction of human hepatic clearance.
Chao P; Uss AS; Cheng KC
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
[TBL] [Abstract][Full Text] [Related]
16. Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes.
Zientek MA; Youdim K
Drug Metab Dispos; 2015 Jan; 43(1):163-81. PubMed ID: 25297949
[TBL] [Abstract][Full Text] [Related]
17. The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America.
Grimm SW; Einolf HJ; Hall SD; He K; Lim HK; Ling KH; Lu C; Nomeir AA; Seibert E; Skordos KW; Tonn GR; Van Horn R; Wang RW; Wong YN; Yang TJ; Obach RS
Drug Metab Dispos; 2009 Jul; 37(7):1355-70. PubMed ID: 19359406
[TBL] [Abstract][Full Text] [Related]
18. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
Zhang Q; Wang GJ
Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
[TBL] [Abstract][Full Text] [Related]
19. Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage.
Emoto C; Murase S; Iwasaki K
Xenobiotica; 2006 Aug; 36(8):671-83. PubMed ID: 16891248
[TBL] [Abstract][Full Text] [Related]
20. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.
Soars MG; Burchell B; Riley RJ
J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
